Net profit of Windlas Biotech declined 4.18% to Rs 16.28 crore in the quarter ended March 2025 as against Rs 16.99 crore during the previous quarter ended March 2024. Sales rose 18.34% to Rs 202.71 crore in the quarter ended March 2025 as against Rs 171.29 crore during the previous quarter ended March 2024.
For the full year,net profit rose 4.81% to Rs 60.99 crore in the year ended March 2025 as against Rs 58.19 crore during the previous year ended March 2024. Sales rose 20.43% to Rs 759.88 crore in the year ended March 2025 as against Rs 630.96 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 202.71 | 171.29 | 18 | 759.88 | 630.96 | 20 |
| OPM % | 12.60 | 12.85 | - | 12.38 | 12.39 | - |
| PBDT | 29.16 | 26.17 | 11 | 107.74 | 90.54 | 19 |
| PBT | 20.82 | 22.63 | -8 | 79.76 | 77.09 | 3 |
| NP | 16.28 | 16.99 | -4 | 60.99 | 58.19 | 5 |